On September 13, Aidea Pharmaceutical dropped more than 10%, along with Sailong Pharmaceutical Group, Kain Technology, Brightgene Bio-Medical Technology Co.,Ltd., Hainan Poly Pharm, and Hongbo Pharmaceutical.
A股创新药板块走低 艾迪药业跌超10%
The innovative drugs sector in the A-share market declined, with jiangsu aidea pharmaceutical falling more than 10%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated